R
476830
vs
K
KOSPI 200
Over the past 12 months, Rznomics Inc has underperformed KOSPI 200, delivering a return of -67% compared to KOSPI 200's +153% growth.
Stocks Performance
476830 vs KOSPI 200
Performance Gap
476830 vs KOSPI 200
Performance By Year
476830 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Rznomics Inc
Glance View
Rznomics, Inc. is a biotechnology company, which engages in the development of ribonucleic acid (RNA) based gene therapies for cancers and intractable diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2025-12-18. The Company’s main products include RNA editing enzyme-based gene therapies, self-circularized RNA structures, and RNA platform technologies. The firm sells its products in domestic and overseas markets.